News

TNX-801 is up to 100,000-fold less virulent than live smallpox vaccine strains and a single dose provides robust immunogenicity and protection against mpox and rabbitpox (more than one year) in ...
Given the number of times this has happened already, it should come as little surprise that we’re now faced with yet another new subvariant of SARS-CoV-2, the virus responsible for COVID.This new ...
today announced the official launch of commercial-stage manufacturing for its first-in-class oligotrophic recombinant adeno-associated virus (rAAV) gene therapy product, developed specifically for ...
Tests have identified Nipah virus in two patients from India’s Kerala state, one of them an 18-year-old woman from Malappuram ...
Tonix Pharmaceuticals (NASDAQ: TNXP) , a fully integrated biopharmaceutical company, announced that Dr. Sina Bavari, Executive Vice President of Infe ...
Effectiveness against both herpes zoster and postherpetic neuralgia remained stable for at least 4 years after vaccination.
Single dose vaccination with TNX-801 protects animals from a lethal challenge with monkeypox, the causative agent of mpox TNX ...